- Home
- HIFS vs QURE Comparison
HIFS vs QURE Comparison
Compare HIFS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIFS | QURE |
|---|---|---|
| Founded | 1834 | 1998 |
| Country | United States | Netherlands |
| Employees | 97 | 248 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.2M | 663.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | HIFS | QURE |
|---|---|---|
| Price | $274.24 | $14.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $44.92 |
| AVG Volume (30 Days) | 45.2K | ★ 4.1M |
| Earning Date | 01-16-2026 | 03-02-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | N/A | $126.12 |
| Revenue Next Year | N/A | $210.54 |
| P/E Ratio | $12.63 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $209.71 | $7.76 |
| 52 Week High | $338.00 | $71.50 |
Technical Indicators
Market Signals| Indicator | HIFS | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 42.29 |
| Support Level | $262.90 | $13.35 |
| Resistance Level | $290.40 | $15.98 |
| Average True Range (ATR) | 9.52 | 1.39 |
| MACD | 1.50 | 0.23 |
| Stochastic Oscillator | 55.22 | 9.77 |
Price Performance
Historical ComparisonAbout HIFS Hingham Institution for Savings
Hingham Institution for Savings is a Massachusetts-chartered savings bank headquartered in Hingham, Massachusetts. The bank is principally engaged in the business of commercial and residential real estate mortgage lending, funded by a mix of retail and commercial deposits, wholesale deposits and borrowings. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending products are residential and commercial mortgage loans secured by properties in eastern Massachusetts. The bank also lends to commercial and residential real estate borrowers and services deposits for customers in the greater Washington, D.C. metropolitan area (WMA) and in the San Francisco Bay Area.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.